Literature DB >> 1554870

The extracellular matrix in human cardiac tissue. Part II: Vimentin, laminin, and fibronectin.

B Speiser1, D Weihrauch, C F Riess, J Schaper.   

Abstract

In continuation of our previous work describing the localization of the collagens type I, III, VI, and IV the present study describes the localization of vimentin, laminin, and fibronectin in human myocardium obtained as left ventricular needle biopsies during cardiac surgery. Myocardium from normal pigs served for comparison. Monoclonal antibodies against the various proteins were used on frozen sections, labeled with fluorescein and viewed in the fluorescence microscope. Vimentin, the intermediate filament of mesenchymal cells, is present in fibroblasts, fibrocytes, and endothelial cells. Laminin is observed in the basal membrane of myocytes, smooth muscle and endothelial cells. The staining intensity for the B1-chain is higher in and around myocytes as compared with the B2-chain antibody, but more blood vessels were stained with the latter. The antibody against the A-chain only stained the basal lamina of vascular cells but not that of myocytes. Fibronectin was localized homogeneously throughout the extracellular space as matrix material in which the cellular elements and the various other proteins such as collagens are embedded. Intracellular staining in myocytes (T-tubules) was commonly observed. Both parts of this study show the distribution of extracellular proteins in normal human cardiac tissue and are intended to be the basis for investigations of pathological changes in diseased human myocardium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554870

Source DB:  PubMed          Journal:  Cardioscience        ISSN: 1015-5007


  13 in total

Review 1.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

Review 2.  Imaging cardiac extracellular matrices: a blueprint for regeneration.

Authors:  Jangwook P Jung; Jayne M Squirrell; Gary E Lyons; Kevin W Eliceiri; Brenda M Ogle
Journal:  Trends Biotechnol       Date:  2011-12-31       Impact factor: 19.536

3.  Myocardial T1 mapping: techniques and potential applications.

Authors:  Jeremy R Burt; Stefan L Zimmerman; Ihab R Kamel; Marc Halushka; David A Bluemke
Journal:  Radiographics       Date:  2014 Mar-Apr       Impact factor: 5.333

4.  Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants.

Authors:  U Gabler; A Berndt; H Kosmehl; U Mandel; L Zardi; S Müller; A Stelzner; D Katenkamp
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

5.  Immunocytochemical detection of enhanced expression of c-myc protein in the heart of cardiomyopathic hamster.

Authors:  N Fujitani; N Kawaguchi; S Toda; S Matsumura; H Kimura; S Onishi
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

Review 6.  Role of extracellular matrix proteins in heart function.

Authors:  V Pelouch; I M Dixon; L Golfman; R E Beamish; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

7.  Right ventricular collagen and fibronectin levels in patients with pulmonary atresia and ventricular septal defect.

Authors:  Theodorus H F Peters; Peter L de Jong; Lennart Klompe; Rolf M F Berger; Pramod R Saxena; Hari S Sharma; Ad J J C Bogers
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

Review 8.  Fibroblasts in post-infarction inflammation and cardiac repair.

Authors:  Wei Chen; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta       Date:  2012-09-07

9.  Assessment of right ventricular fibrosis in different forms of pulmonary atresia with ventricular septal defect.

Authors:  Pieter C van de Woestijne; Lennart Klompe; Peter L de Jong; Theodorus Hf Peters; Arie P Kappetein; Hari S Sharma; Ad Jjc Bogers
Journal:  Exp Clin Cardiol       Date:  2004

10.  Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue.

Authors:  Milica Radisic; Hyoungshin Park; Timothy P Martens; Johanna E Salazar-Lazaro; Wenliang Geng; Yadong Wang; Robert Langer; Lisa E Freed; Gordana Vunjak-Novakovic
Journal:  J Biomed Mater Res A       Date:  2008-09       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.